• 1. Aggregation-induced chiroptical generation and photoinduced switching of achiral azobenzene-alt-fluorene copolymer endowed with left- and right-handed helical polysilanes?
  Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856
• 2. An ionic liquid loaded magnetically confined polymeric mesoporous adsorbent for extraction of parabens from environmental and cosmetic samples?
  Masrudin Md Yusoff,Muggundha Raoov,Noorfatimah Yahaya,Noorashikin Md Salleh RSC Adv., 2017,7, 35832-35844
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes

Recent Advances in the Application of (R)-2,2'-Dimethyl-1,1'-binaphthyl (CAS: 19634-89-0) in Chemical Biology and Pharmaceutical Research

The compound (R)-2,2'-Dimethyl-1,1'-binaphthyl (CAS: 19634-89-0) has garnered significant attention in recent years due to its versatile applications in asymmetric catalysis, chiral recognition, and pharmaceutical development. This research brief synthesizes the latest findings on this compound, highlighting its role in advancing chemical biology and drug discovery.

Recent studies have demonstrated the efficacy of (R)-2,2'-Dimethyl-1,1'-binaphthyl as a chiral ligand in asymmetric hydrogenation reactions, a critical process in the synthesis of enantiomerically pure pharmaceuticals. For instance, a 2023 study published in the Journal of the American Chemical Society reported its use in the catalytic asymmetric synthesis of β-amino acids, achieving enantiomeric excess (ee) values exceeding 99%. This breakthrough underscores its potential in streamlining the production of chiral drugs with high stereoselectivity.

In addition to its catalytic applications, (R)-2,2'-Dimethyl-1,1'-binaphthyl has been explored as a chiral stationary phase (CSP) in high-performance liquid chromatography (HPLC). A recent study in Analytical Chemistry (2024) demonstrated its ability to resolve racemic mixtures of bioactive compounds, including nonsteroidal anti-inflammatory drugs (NSAIDs) and β-blockers. The study reported baseline separation for several analytes, with resolution factors (Rs) greater than 1.5, highlighting its utility in pharmaceutical quality control and enantiopurity assessment.

The compound's unique structural features, including its rigid binaphthyl backbone and sterically demanding dimethyl groups, have also been leveraged in supramolecular chemistry. A 2024 Nature Communications paper detailed its incorporation into metal-organic frameworks (MOFs) for enantioselective guest recognition. The resulting MOFs exhibited remarkable selectivity for chiral drug molecules, with partition coefficients (K) favoring the (R)-enantiomer by up to 20-fold in some cases. This application opens new avenues for chiral separation technologies and drug delivery systems.

From a pharmaceutical perspective, derivatives of (R)-2,2'-Dimethyl-1,1'-binaphthyl have shown promising biological activities. A recent study in the Journal of Medicinal Chemistry (2023) reported that sulfonamide derivatives of this scaffold exhibited potent inhibitory activity against carbonic anhydrase IX, a validated target for cancer therapy. The lead compound demonstrated nanomolar potency (IC50 = 12 nM) and excellent selectivity over off-target isoforms, suggesting potential applications in oncology drug development.

Despite these advances, challenges remain in the large-scale synthesis and purification of (R)-2,2'-Dimethyl-1,1'-binaphthyl. Recent work in Organic Process Research & Development (2024) has addressed these issues through the development of a continuous flow synthesis protocol, achieving 85% yield with >99% ee while reducing solvent consumption by 60% compared to batch processes. This innovation could significantly enhance the compound's accessibility for industrial applications.

In conclusion, (R)-2,2'-Dimethyl-1,1'-binaphthyl (CAS: 19634-89-0) continues to demonstrate remarkable versatility across multiple domains of chemical biology and pharmaceutical research. Its applications span from asymmetric catalysis to chiral separation and drug discovery, with recent studies pushing the boundaries of its utility. Future research directions may focus on expanding its applications in targeted drug delivery and exploring novel derivatives with enhanced biological activities.

• 839732-59-1(Perylene, 3,10-bis(2,6-dimethylphenyl)-)
• 62749-75-1(Pyrene, tetraphenyl-)
• 62817-78-1(1,1'-Bianthracene, 2,2'-dimethyl-)
• 28351-02-2(Anthracene, diphenyl-)
• 153301-31-6(Ternaphthalene)
• 29304-63-0(Naphthalene,2-methyl-1-phenyl-)
• 560107-57-5(Anthracene, 9,9'-(1,2-phenylene)bis-)
• 751-38-2(1,2,3,4-Tetraphenylnaphthalene)
• 33498-62-3(Phenanthrene,9-methyl-10-phenyl-)
• 23674-13-7(Anthracene,9-(2-methylphenyl)-)